Metraipolis › archive › dc_e28b2c290256
An Integrated Immunometabolic Signature Predicts Prognosis and Immunotherapy Response in ccRCC and Identifies UCN-Mediated Immune Evasion as a Therapeutic… — Europe PMC PMID:42122169
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42122169
- DOI
- 10.3390/cancers18091373
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-03T06:49:27.645Z
- SHA-256 of the archived text
cfc6f417168b50c495e58c9a40e258be03b5d25d9ff8d74469c898e88bbab7f5- Stable URL of this page
https://metraipolis.com/documento/dc_e28b2c290256
How to cite
An Integrated Immunometabolic Signature Predicts Prognosis and Immunotherapy Response in ccRCC and Identifies UCN-Mediated Immune Evasion as a Therapeutic… — Europe PMC PMID:42122169 — Europe PMC (en), https://europepmc.org/article/MED/42122169 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_e28b2c290256 (Metraipolis archive dc_e28b2c290256, sha256 cfc6f417168b50c495e58c9a40e258be03b5d25d9ff8d74469c898e88bbab7f5)
BibTeX
@misc{dce28b2c290256,
title = {An Integrated Immunometabolic Signature Predicts Prognosis and Immunotherapy Response in ccRCC and Identifies UCN-Mediated Immune Evasion as a Therapeutic… — Europe PMC PMID:42122169},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42122169},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_e28b2c290256; sha256 cfc6f417168b50c495e58c9a40e258be03b5d25d9ff8d74469c898e88bbab7f5},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42122169. Agents can read the archived copy with the MCP tool read_document.